Data Collection: Gathering extensive data from diverse populations requires significant financial resources. Technological Infrastructure: Sophisticated tools and software for data analysis and disease modeling are costly. Human Resources: Hiring and training epidemiologists, data scientists, and healthcare workers involves substantial expenditure. Surveillance Systems: Maintaining and upgrading systems for continuous disease monitoring is expensive. Clinical Trials: Conducting trials to test new interventions or treatments demands high financial investment.